These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 24683611)

  • 1. Could cholesterol-lowering drugs cause cataracts?
    Harv Mens Health Watch; 2014 Jan; 18(6):8. PubMed ID: 24683611
    [No Abstract]   [Full Text] [Related]  

  • 2. [Strengthened support for statin therapy as secondary prevention. Doubtful evidence for more intensive lowering of cholesterol levels].
    HÃ¥kansson J
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1234-5. PubMed ID: 21786497
    [No Abstract]   [Full Text] [Related]  

  • 3. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
    Olsson AG
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
    [No Abstract]   [Full Text] [Related]  

  • 4. The power of statins: aggressive lipid lowering.
    Jones PH
    Postgrad Med; 2002 Oct; 112(4 Suppl):23-30. PubMed ID: 19667597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ezetimib as combination partner in hypercholesteremia. Lowering LDL beyond the effect of statins].
    Sudhop T; von Bergmann K
    MMW Fortschr Med; 2003 Apr; 145(16):48-50. PubMed ID: 14606402
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interactions between statins and macrolide antibiotics].
    Molden E; Andersson KS; Jacobsen D
    Tidsskr Nor Laegeforen; 2007 Jun; 127(12):1660-1. PubMed ID: 17571108
    [No Abstract]   [Full Text] [Related]  

  • 7. [Statins plus cholesterol resorption inhibitor. LDL goal values attainable].
    MMW Fortschr Med; 2002 Sep; 144(38):56. PubMed ID: 12395708
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum cholesterol, use of lipid-lowering drugs, and risk of Parkinson disease.
    de Lau LM; Stricker BH; Breteler MM
    Mov Disord; 2007 Oct; 22(13):1985. PubMed ID: 17557354
    [No Abstract]   [Full Text] [Related]  

  • 9. [Low carbohydrate diets reduce the need of statin treatment].
    Ravnskov U
    Lakartidningen; 2006 Oct 4-10; 103(40):3017; author reply 3017-8. PubMed ID: 17115674
    [No Abstract]   [Full Text] [Related]  

  • 10. Statins after intracerebral hemorrhage: to treat or not to treat.
    Goldstein LB
    Arch Neurol; 2011 May; 68(5):565-6. PubMed ID: 21220651
    [No Abstract]   [Full Text] [Related]  

  • 11. Evidence-based prediction of statin use with lipid-panel data from the National Health and Nutrition Examination Survey.
    Gorevski E; Bian B; Kelton CM; Martin Boone JE; Guo JJ
    Value Health; 2012 Jan; 15(1):32-8. PubMed ID: 22264969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cholesterol drugs: should you be taking one?
    Consum Rep; 1998 Oct; 63(10):54-5. PubMed ID: 10342966
    [No Abstract]   [Full Text] [Related]  

  • 13. Ask the doctor. I have just stopped taking a statin drug because it was causing muscle pain. To control my cholesterol I'm now taking ground flaxseed and a daily red yeast rice pill. Are these supplements effective for lowering cholesterol?
    Fabiny A
    Harv Womens Health Watch; 2014 Mar; 21(7):2. PubMed ID: 24941469
    [No Abstract]   [Full Text] [Related]  

  • 14. [Inhibition of cholesterol synthesis and cataract].
    Hockwin O; Kojima M; Czubayko F; von Bergmann K
    Fortschr Ophthalmol; 1991; 88(4):393-5. PubMed ID: 1786929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Research relating the use of systematic drug and cataracts].
    Lei JY; Yao K
    Zhonghua Yan Ke Za Zhi; 2013 May; 49(5):468-71. PubMed ID: 24021188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is your cholesterol drug putting you at risk for vision loss?
    Harv Health Lett; 2013 Dec; 39(2):8. PubMed ID: 24634971
    [No Abstract]   [Full Text] [Related]  

  • 17. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety.
    Hou R; Goldberg AC
    Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and risk of incident diabetes.
    Mascitelli L; Pezzetta F; Goldstein MR
    Lancet; 2010 Jun; 375(9732):2140-1; author reply 2141-2. PubMed ID: 20609947
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the current debate on lowering LDL cholesterol with ezetimibe].
    Breuer HW
    Dtsch Med Wochenschr; 2010 Nov; 135(44):2201; author reply 2202. PubMed ID: 20979008
    [No Abstract]   [Full Text] [Related]  

  • 20. By the way, doctor...I read about Baycol, the cholesterol-lowering drug being taken off the market because it caused fatal muscle damage. I don't take it, but I do take another statin. Should I be worried?
    Lee TH
    Harv Health Lett; 2001 Nov; 27(1):8. PubMed ID: 11724700
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.